Docality.com Logo
 
Dr. George  Revtyak  Md image

Dr. George Revtyak Md

1801 N Senate Blvd Suite 310
Indianapolis IN 46202
317 622-2500
Medical School: Indiana University School Of Medicine - 1978
Accepts Medicare: Yes
Participates In eRX: Yes
Participates In PQRS: Yes
Participates In EHR: Yes
License #:
NPI: 1902867286
Taxonomy Codes:
207RC0000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. George Revtyak is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:92980 Description:Insert intracoronary stent Average Price:$1,914.00 Average Price Allowed
By Medicare:
$777.82
HCPCS Code:36200 Description:Place catheter in aorta Average Price:$1,000.00 Average Price Allowed
By Medicare:
$105.93
HCPCS Code:93460 Description:R&l hrt art/ventricle angio Average Price:$1,073.00 Average Price Allowed
By Medicare:
$331.07
HCPCS Code:75710 Description:Artery x-rays arm/leg Average Price:$778.33 Average Price Allowed
By Medicare:
$53.04
HCPCS Code:93459 Description:L hrt art/grft angio Average Price:$960.00 Average Price Allowed
By Medicare:
$285.44
HCPCS Code:93458 Description:L hrt artery/ventricle angio Average Price:$858.00 Average Price Allowed
By Medicare:
$226.34
HCPCS Code:75716 Description:Artery x-rays arms/legs Average Price:$667.27 Average Price Allowed
By Medicare:
$61.76
HCPCS Code:93454 Description:Coronary artery angio s&i Average Price:$690.00 Average Price Allowed
By Medicare:
$163.73
HCPCS Code:75625 Description:Contrast x-ray exam of aorta Average Price:$546.86 Average Price Allowed
By Medicare:
$53.77
HCPCS Code:33967 Description:Insert ia percut device Average Price:$635.00 Average Price Allowed
By Medicare:
$172.44
HCPCS Code:92981 Description:Insert intracoronary stent Average Price:$533.00 Average Price Allowed
By Medicare:
$216.30
HCPCS Code:99223 Description:Initial hospital care Average Price:$414.22 Average Price Allowed
By Medicare:
$187.39
HCPCS Code:99220 Description:Initial observation care Average Price:$352.64 Average Price Allowed
By Medicare:
$171.11
HCPCS Code:99222 Description:Initial hospital care Average Price:$274.93 Average Price Allowed
By Medicare:
$127.36
HCPCS Code:99239 Description:Hospital discharge day Average Price:$218.13 Average Price Allowed
By Medicare:
$99.01
HCPCS Code:99233 Description:Subsequent hospital care Average Price:$212.52 Average Price Allowed
By Medicare:
$96.34
HCPCS Code:99232 Description:Subsequent hospital care Average Price:$148.67 Average Price Allowed
By Medicare:
$67.20
HCPCS Code:99213 Description:Office/outpatient visit est Average Price:$145.58 Average Price Allowed
By Medicare:
$66.84
HCPCS Code:93000 Description:Electrocardiogram complete Average Price:$50.00 Average Price Allowed
By Medicare:
$17.83

HCPCS Code Definitions

93454
Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation
99232
Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit.
99213
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.
99233
Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: A detailed interval history; A detailed examination; Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is unstable or has developed a significant complication or a significant new problem. Typically, 35 minutes are spent at the bedside and on the patient's hospital floor or unit.
99239
Hospital discharge day management; more than 30 minutes
36200
Introduction of catheter, aorta
93000
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report
33967
Insertion of intra-aortic balloon assist device, percutaneous
75710
Angiography, extremity, unilateral, radiological supervision and interpretation
75625
Aortography, abdominal, by serialography, radiological supervision and interpretation
75716
Angiography, extremity, bilateral, radiological supervision and interpretation
93458
Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed
93460
Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed
93459
Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography
99222
Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of moderate severity. Typically, 50 minutes are spent at the bedside and on the patient's hospital floor or unit.
99223
Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of high severity. Typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit.
99220
Initial observation care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission to "observation status" are of high severity. Typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit.

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1356312896
Cardiac Electrophysiology
3,691
1154349454
Cardiovascular Disease (Cardiology)
1,733
1942274279
Cardiovascular Disease (Cardiology)
1,707
1770526899
Diagnostic Radiology
1,394
1568565455
Pulmonary Disease
1,245
1922014745
Cardiovascular Disease (Cardiology)
987
1134187701
Cardiovascular Disease (Cardiology)
943
1386680536
Diagnostic Radiology
878
1447215777
Cardiovascular Disease (Cardiology)
863
1326039272
Medical Oncology
851
*These referrals represent the top 10 that Dr. Revtyak has made to other doctors

Publications

Treatment of radial artery occlusions using balloon angioplasty and localized intra-arterial abciximab. - Journal of interventional cardiology
To study an alternative strategy for the treatment of radial artery occlusion (RAO) using balloon angioplasty and intrathrombus administration of abciximab.RAO is a well-described complication of transradial procedures. The optimal method to restore the patency of the radial artery following its occlusion remains unclear. Spontaneous recanalization can occur in some patients and systemic anticoagulation can be recommended but is often unsuccessful.A retrospective review of all patients in our database from 2009 to 2013 with RAO who underwent treatment with balloon angioplasty and intra-arterial abciximab administered directly at the site of occlusion.Four patients with symptomatic RAO following transradial catheterization were treated with balloon angioplasty and a 90-second intrathrombus infusion of abciximab. All procedures were successful and patency was documented the following day with duplex sonography and again at follow-up (mean 189 days). The patients also remained free of symptoms at follow-up. The fifth patient was treated with balloon angioplasty alone. This patient suffered symptomatic reocclusion of the radial artery.Balloon angioplasty and intrathrombus administration of abciximab via a catheter appears to be a safe, effective, and durable technique for reestablishing the patency of an occluded radial artery following transradial catheterization. Larger studies are needed to confirm our findings and establish the role for this technique in an algorithm for treatment of RAO.© 2014, Wiley Periodicals, Inc.
Intracoronary glycoprotein IIb/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden: results from the ClearWayâ„¢ Multicenter Registry. - Cardiovascular revascularization medicine : including molecular interventions
This multicenter registry aimed to assess the ClearWay™ (CW) perfusion catheter in reduction of thrombus burden and improvement of the coronary flow during percutaneous coronary intervention (PCI).The presence or development of thrombus during PCI is associated with poor prognosis.The utility of the CW perfusion catheter was assessed in patients who presented with intracoronary thrombus and were subjected to PCI. Data were collected by online survey from 15 US sites. Angiographic assessment of the coronary thrombus burden and the coronary flow after intracoronary infusion of glycoprotein (GP) IIb/IIIa inhibitors via the CW catheter was evaluated at baseline, immediately after infusion, and at the end of the procedure. The cohort included 102 patients; 71.6% presented with ST-elevation myocardial infarction (MI), 21.6% with non-ST-elevation MI, 5.9% with stable angina pectoris, and 2.9% with silent ischemia. The mean cohort age was 59.9±14.5years and comprised mostly of men (72.5%).GP IIb/IIIa inhibitors were infused via the CW catheter on average 1.1±0.3 times, with a mean pressure of 4.2±2.7atm and a mean infusion time of 55±55s. Following the infusion, Thrombolysis In Myocardial Infarction (TIMI) flow improved by 1° in 71 patients (69.6%) and by 2° in 51 patients (50%), while visible thrombus was reduced by 52% (p<0.001). In the final angiogram, TIMI flow was restored in 90.2% and clearance of a visible thrombus was obtained in 91.8% of the lesions.Intracoronary infusion of GP IIb/IIIa inhibitors via the perfusion CW catheter is associated with significant reduction in thrombus burden and with improvement of the coronary flow in patients presenting or developing thrombus burden during PCI.Copyright © 2013. Published by Elsevier Inc.
Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry. - Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
It is unclear how well the long-term safety and effectiveness of drug-eluting stents observed in tightly defined randomized controlled trials (RCT) translates to expanded use in routine practice.The FDA-mandated TAXUS Express(2) ARRIVE 1 postmarket registry was designed to consecutively enroll patients receiving > or = 1 TAXUS stent in low-, medium-, and high-volume US sites (n = 50). All cardiac events plus an additional 20% sample of records were monitored and all endpoints were independently adjudicated.Detailed follow-up data through 2 years were compiled for 2,487 patients (95%). Simple-use (on-label) ARRIVE 1 patients (35%) had outcomes similar to 4 pooled TAXUS RCTs for death (3.5% vs. 3.4%, respectively, P = 0.78), Q-wave myocardial infarction (QWMI, 0.7% vs. 0.9%, P = 0.72), and stent thrombosis (ST, 2.2% vs. 1.2%, P = 0.12), but lower target vessel revascularization (7.8% vs. 13.4%, P < 0.0001). Compared with simple-use, cases representing expanded use to treat broader patient/lesion characteristics showed higher 2-year rates for death (7.4% vs. 3.5%, respectively, P = 0.0003), target lesion revascularization (9.4% vs. 5.8%, P = 0.0031), and ST (3.4% vs. 2.2%, P = 0.061, concentrated early in the first year).By including methods usually found in RCT, ARRIVE 1 captured a broad spectrum of disease treated in standard practice with high levels of ascertainment of clinical outcomes. In the more complicated cases, expectedly higher adverse event rates were seen compared to that found in the simple-use cases or pivotal RCT. These results have now been included in the Directions for Use, to aid in physician and patient decision-making.2008 Wiley-Liss, Inc.

Map & Directions

1801 N Senate Blvd Suite 310 Indianapolis, IN 46202
View Directions In Google Maps

Nearby Doctors

702 Barnhill Dr Riley Hospital
Indianapolis, IN 46202
317 744-4034
1801 N Senate Blvd Ste 535
Indianapolis, IN 46202
317 631-1950
535 Barnhill Dr.
Indianapolis, IN 46202
317 744-4622
1801 N Senate Blvd Suite 535
Indianapolis, IN 46202
317 631-1950
1801 N Senate Blvd Suite 355
Indianapolis, IN 46202
317 248-8420
550 University Blvd Uh 1501
Indianapolis, IN 46202
317 481-1310
541 Clinical Drive, Room 370 Indiana University School Of Medicine
Indianapolis, IN 46202
314 165-5305